Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Myofascial pain; Pelvic pain
- Focus Therapeutic Use
- 17 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Feb 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
- 14 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.